Welcome Guest | Register / Login

Global IV Iron Drugs Market Report: 2014 Edition

Table of Contents

1. Iron in Human Body: An Overview
1.1 IV Iron Application Areas
1.1.1 IV Iron Application in Nephrology
1.2 Iron Deficiency  Anemia
1.2.2 Iron Deficiency Metrics
1.3 IV Iron Therapies for Anemia Treatment

2. Market Analysis
2.1 Global Iron Products Market
Market Value
Market Segments
2.1.1 Global IV Iron Market
Market Value
2.2 The US IV Iron Market
Market Value
NonDialysis IV Iron Market

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Improved Quality of Treatment outside Dialysis
3.1.2 Increasing Global Healthcare Expenditure
3.1.3 Shift from Rural to Urban Regions
3.1.4 Accelerating Aging Population
3.1.5 Increase in Number of Dialysis Cases
3.1.6 Growing Number of People Suffering from Hypertension
3.1.7 Improving Economic Conditions
3.1.8 Increasing Life Expectancy Rate
3.1.9 Increasing Coverage of Health Insurances
3.1.10 Rising Medicines Expenditures
3.2 Trends & Developments
3.2.1 Novel Product Development
3.2.2 Bundled Payment System
3.2.3 Increasing Penetration in Gynecology Sector
3.3 Challenges
3.3.1 Strict Regulatory Structures
3.3.2 Associated Adverse Effects with IV Iron Products

4. Competitive Landscape
4.1 The US
4.1.1 The US Non Dialysis IV Iron Market
4.2 Product Contention

5. Company Profiles
5.1 Galenica Pharmaceuticals
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Expansion into New Areas of Pharma Segment
Focus on Broadening Partnerships
5.2 Actavis Inc.
5.2.1 Business Description
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on Strategic Acquisitions & Partnerships
Expansion of Generic Product Line
5.3 AMAG Pharmaceuticals
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Portfolio Expansion
Ceaseless Research & Development

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables

Risk Factors for CKD
FDA Approved IV Iron Products
SFP Clinical Trials
IV Iron Products – Safety Profile
IV Iron Administration Comparison
Dependent & Independent Variables (20072013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Charts

Global Iron Products Market (20092013)
Global Iron Products Market Share – by Segments (2013)
Global Iron Products Value – by Segments (2013)
Global IV Iron Market (20092013)
The US IV Iron Market Size (20092013)
US NonDialysis IV Iron Market (20112013)
IV Iron – Avoidance of ESA Initiation in Pre Dialysis Patients
Global Health Care Expenditure Per Capita (20072012)
The US Healthcare Expenditure per Capita (20072012)
Global Urban Population (20072012)
The US Urban Population (20072012)
Global Aging Population (Over 65) as a Percentage of Total Population (20082012)
The US Aging Population (20082012)
Global Dialysis Patient Population
Dialysis Patient Population Share by Region (2012)
Worldwide Patients with End Stage Renal Disease (20052013)
Hypertension Prevalence in the US (20102015E)
Hypertension Prevalence in the Developed Europe (20102015E)
Global GDP (20072012)
World Gross National Income (20082012)
Global Life Expectancy Rate (20072012)
The US Life Expectancy Rate (20072013E)
Global Insurance Density (20042013)
Global Spending on Medicines (20062016E)
Global Spending on Medicine Share by Region (20062016E)
The US Spending on Medicine (20072016E)
Japan’s Spending on Medicine (20072016E)
Long and Short Term Concerns about IV Iron
IV Iron Market Share in the US (2013E)
NonDialysis IV Iron Market in the US – by Volume (Q114)
Galenica’s Revenue Share by Business Segments (2012)
Galenica’s Net Sales and Net Profit (20092013)
Actavis’ Revenue Share by Business Segment (2013)
Actavis’ Revenues and Net Income (20092013)
AMAG Pharmaceuticals’ Revenues (20092013)
Global IV Iron Market Forecast (20092018F)

Why http://www.marketreportsonline.com/
Published By :Koncept Analytics